ASX - By Stock
|
ADR |
Re:
Ann: Investor Presentation
|
|
CM662
|
30 |
6.5K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
30
|
6.5K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
CM662
|
96 |
21K |
0 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
96
|
21K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Investor Presentation
|
|
CM662
|
30 |
6.5K |
2 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
30
|
6.5K
|
2
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Investor Presentation
|
|
CM662
|
30 |
6.5K |
8 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
30
|
6.5K
|
8
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Investor Presentation
|
|
CM662
|
30 |
6.5K |
1 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
30
|
6.5K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: UK Private Insurer Approves Reimbursement for OncoSil
|
|
CM662
|
26 |
6.0K |
0 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
26
|
6.0K
|
0
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Appendix 4D and Half Year Financial Report
|
|
CM662
|
14 |
4.1K |
5 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
14
|
4.1K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Why OSL is a Multi-Bagger
|
|
CM662
|
55 |
21K |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
55
|
21K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: New CEO Appointed - Dr Paul Mastoridis
|
|
CM662
|
39 |
12K |
2 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
39
|
12K
|
2
|
|
ASX - By Stock
|
ADR |
Re:
Ann: New CEO Appointed - Dr Paul Mastoridis
|
|
CM662
|
39 |
12K |
1 |
04/02/24 |
04/02/24 |
ASX - By Stock
|
39
|
12K
|
1
|
|
ASX - By Stock
|
ADR |
Re:
Ann: New CEO Appointed - Dr Paul Mastoridis
|
|
CM662
|
39 |
12K |
0 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
39
|
12K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: New CEO Appointed - Dr Paul Mastoridis
|
|
CM662
|
39 |
12K |
0 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
39
|
12K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: New CEO Appointed - Dr Paul Mastoridis
|
|
CM662
|
39 |
12K |
1 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
39
|
12K
|
1
|
|
ASX - By Stock
|
ADR |
Re:
Ann: New CEO Appointed - Dr Paul Mastoridis
|
|
CM662
|
39 |
12K |
0 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
39
|
12K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: New CEO Appointed - Dr Paul Mastoridis
|
|
CM662
|
39 |
12K |
4 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
39
|
12K
|
4
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
CM662
|
9 |
3.1K |
6 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
9
|
3.1K
|
6
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Resignation of CEO
|
|
CM662
|
29 |
8.3K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
29
|
8.3K
|
1
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Resignation of CEO
|
|
CM662
|
29 |
8.3K |
3 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
29
|
8.3K
|
3
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Resignation of CEO
|
|
CM662
|
29 |
8.3K |
5 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
29
|
8.3K
|
5
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Resignation of CEO
|
|
CM662
|
29 |
8.3K |
1 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
29
|
8.3K
|
1
|
|
ASX - By Stock
|
RSH |
Re:
Ann: EIQ: EIQ Licenses Software to Respiri - Remote Patient Mon.
|
|
CM662
|
17 |
3.9K |
3 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
17
|
3.9K
|
3
|
|
ASX - By Stock
|
RSH |
Re:
Ann: $6.5m raised for US expansion, $20m commitment secured
|
|
CM662
|
77 |
20K |
0 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
77
|
20K
|
0
|
|
ASX - By Stock
|
RSH |
Re:
Ann: $6.5m raised for US expansion, $20m commitment secured
|
|
CM662
|
77 |
20K |
1 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
77
|
20K
|
1
|
|
ASX - By Stock
|
RSH |
Re:
Ann: $6.5m raised for US expansion, $20m commitment secured
|
|
CM662
|
77 |
20K |
5 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
77
|
20K
|
5
|
|
ASX - By Stock
|
RSH |
Re:
Ann: $6.5m raised for US expansion, $20m commitment secured
|
|
CM662
|
77 |
20K |
4 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
77
|
20K
|
4
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Resignation of CEO
|
|
CM662
|
29 |
8.3K |
7 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
29
|
8.3K
|
7
|
|
ASX - By Stock
|
ADR |
Re:
Ann: First Order of Hailie Sensors to US Intermountain Health
|
|
CM662
|
52 |
13K |
4 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
52
|
13K
|
4
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Completion of Share Consolidation
|
|
CM662
|
11 |
4.2K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
11
|
4.2K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Production and US Market Release of Advanced Smartinhaler
|
|
CM662
|
10 |
3.0K |
0 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
10
|
3.0K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Results of Meeting & Approval of Share Consolidation
|
|
CM662
|
6 |
1.5K |
1 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
6
|
1.5K
|
1
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Monsoon Twilight Investor Briefing Presentation
|
|
CM662
|
12 |
3.3K |
0 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
12
|
3.3K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Monsoon Twilight Investor Briefing Presentation
|
|
CM662
|
12 |
3.3K |
2 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
12
|
3.3K
|
2
|
|
ASX - By Stock
|
ADR |
Re:
Ann: First Patients Enrolled at SENTA Partners in the US
|
|
CM662
|
9 |
1.8K |
0 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
9
|
1.8K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Consolidation/Split - ADR
|
|
CM662
|
14 |
3.6K |
1 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
14
|
3.6K
|
1
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
CM662
|
22 |
5.1K |
1 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
22
|
5.1K
|
1
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
CM662
|
22 |
5.1K |
2 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
22
|
5.1K
|
2
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
CM662
|
22 |
5.1K |
3 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
22
|
5.1K
|
3
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
CM662
|
22 |
5.1K |
3 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
22
|
5.1K
|
3
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
CM662
|
22 |
5.1K |
3 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
22
|
5.1K
|
3
|
|
ASX - By Stock
|
ADR |
New CTO @ ADR ? - No Announcement to date !
|
|
CM662
|
1 |
536 |
1 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
1
|
536
|
1
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
CM662
|
24 |
4.4K |
6 |
28/10/23 |
28/10/23 |
ASX - By Stock
|
24
|
4.4K
|
6
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Adherium to integrate Hailie into CareCentra AI platform
|
|
CM662
|
17 |
3.6K |
0 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
17
|
3.6K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Adherium to integrate Hailie into CareCentra AI platform
|
|
CM662
|
17 |
3.6K |
3 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
17
|
3.6K
|
3
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Adherium to integrate Hailie into CareCentra AI platform
|
|
CM662
|
17 |
3.6K |
1 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
17
|
3.6K
|
1
|
|
ASX - By Stock
|
ADR |
The Silent CEO
|
|
CM662
|
0 |
274 |
1 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
0
|
274
|
1
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Production & market release of new, next generation sensors
|
|
CM662
|
10 |
2.3K |
4 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
10
|
2.3K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
CM662
|
62 |
17K |
2 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
62
|
17K
|
2
|
|
ASX - By Stock
|
ADR |
Re:
Ann: New Major Asthma Partnership with US-Based SENTA partners
|
|
CM662
|
19 |
5.2K |
0 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
19
|
5.2K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: New Major Asthma Partnership with US-Based SENTA partners
|
|
CM662
|
19 |
5.2K |
3 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
19
|
5.2K
|
3
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Accelerating Commercialisation with Largest US A&A Practice
|
|
CM662
|
26 |
8.1K |
0 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
26
|
8.1K
|
0
|
|